Ivan Kairatov is a Biopharma expert with a deep knowledge of technology and innovation in the industry and extensive experience in research and development. In this interview, we delve into the topic of refget Sequence Collections, a new tool developed to increase the efficiency of genomic
Glycomine, a leading biotechnology company based in San Francisco, has achieved a notable milestone by raising $115 million in funding for their pioneering project, GLM101. This development is particularly significant in an economic environment where securing substantial capital remains
In the ongoing battle against water contamination, few pollutants have proven as tenacious as per- and polyfluoroalkyl substances (PFAS), frequently dubbed “forever chemicals.” These resistant compounds are omnipresent in various products, including food packaging and nonstick coatings, posing env
The evolution of precision medicine is transforming the landscape of rare disease care, offering new hope through advanced diagnostic and treatment strategies. With the advent of genomic sequencing, patients and families are experiencing a shift from despair to optimism as they navigate complex
Ivan Kairatov is a distinguished figure in the biopharma industry, renowned for his expertise in tech and innovation within the field. With a robust background in research and development, Ivan has substantially influenced advancements in cellular therapies and drug development. Today, we delve
The rapid development of AI technologies has led to increasing instances of humans forming intimate relationships with AI entities. Psychologists, in an opinion paper published in the journal Trends in Cognitive Sciences, discuss the nuanced ethical issues arising from these relationships,
